| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/24/2012 | US20120129947 Amino-alcohol analogues and uses thereof |
| 05/24/2012 | US20120129918 Modified oligonucleotides for telomerase inhibition |
| 05/24/2012 | US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 05/24/2012 | US20120129916 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 05/24/2012 | US20120129913 dsRNA For Treating Viral Infection |
| 05/24/2012 | US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics |
| 05/24/2012 | US20120129882 Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition |
| 05/24/2012 | US20120129860 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 05/24/2012 | US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
| 05/24/2012 | US20120129849 Deuterated serine-threonine protein kinase modulators |
| 05/24/2012 | US20120129778 Ligand that bind tgf-beta receptor rii |
| 05/24/2012 | US20120129770 Novel polynucleotide molecules for enhanced gene expression |
| 05/24/2012 | US20120129727 Efficient and effective supplement screening for the development of chemically defined media in cell culture |
| 05/24/2012 | US20120129262 Methods of Modifying Transcriptional Regulatory Networks in Stem Cells |
| 05/24/2012 | US20120129261 Transcriptome Transfer Produces Cellular Phenotype Conversion |
| 05/24/2012 | US20120129260 Method for producing pluripotent stem cells |
| 05/24/2012 | US20120129259 Method for producing a coated cell culture carrier |
| 05/24/2012 | US20120129258 Cell chip and method of fabricating the same |
| 05/24/2012 | US20120129257 Apparatus For Culturing Anchorage Dependent Cells |
| 05/24/2012 | US20120129256 Method of preparing pluripotent stem cells |
| 05/24/2012 | US20120129255 Functionalization of silk material by avidin-biotin interaction |
| 05/24/2012 | US20120129254 Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same |
| 05/24/2012 | US20120129253 Adipose tissue-derived stromal cells and methods of isolating and using the same |
| 05/24/2012 | US20120129252 Method and system for cell filtration |
| 05/24/2012 | US20120129251 Method for deparaffinizing formalin-fixed paraffin-embedded tissue |
| 05/24/2012 | US20120129225 Methods and reagents for molecular cloning |
| 05/24/2012 | US20120129219 Antibody Molecules Which Bind Human IL-17 |
| 05/24/2012 | US20120129218 Cofilin knockdown host cells and uses thereof |
| 05/24/2012 | US20120129211 Titration of differentiation medium components |
| 05/24/2012 | US20120129209 Aligning cells on wrinkled surface |
| 05/24/2012 | US20120129208 Honeycomb shrink wells for stem cell culture |
| 05/24/2012 | US20120129207 Compositions and methods of functionally enhanced in vitro cell culture system |
| 05/24/2012 | US20120129199 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs |
| 05/24/2012 | US20120129189 Methods of Controlling Cell Proliferation |
| 05/24/2012 | US20120129161 Methods for modulating embryonic stem cell differentiation |
| 05/24/2012 | US20120129147 Method of preparing controls for glycated hemoglobin s-a1c derived from healthy blood cells |
| 05/24/2012 | US20120128845 Ice, toxicity, thermal-stress and cold-fracture management during cryopreserving encapsulation of specimens using controlled ice nucleation |
| 05/24/2012 | US20120128782 Multicomponent Degradable Cationic Polymers |
| 05/24/2012 | US20120128770 Treatment of insulin resistance and obesity by stimulating glp-1 release |
| 05/24/2012 | US20120128761 Lipophilic Polynucleotide Conjugates |
| 05/24/2012 | US20120128739 Three-dimensional nanostructured hybrid scaffold and manufacture thereof |
| 05/24/2012 | US20120128725 Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction |
| 05/24/2012 | US20120128723 Cancer specific antibody and cell surface proteins |
| 05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
| 05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
| 05/24/2012 | US20120128697 NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis |
| 05/24/2012 | US20120128696 Methods for detecting and inhibiting angiogenesis |
| 05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
| 05/24/2012 | US20120128692 Human cytomegalovirus neutralizing antibodies and use thereof |
| 05/24/2012 | US20120128691 Human cytomegalovirus neutralizing antibodies and use thereof |
| 05/24/2012 | US20120128689 Anti-il-23 immunoglobulins |
| 05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
| 05/24/2012 | US20120128677 Pancreatic cancer targets and uses thereof |
| 05/24/2012 | US20120128676 Muc1 antibodies |
| 05/24/2012 | US20120128669 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 05/24/2012 | US20120128666 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid |
| 05/24/2012 | US20120128664 Glycosylated antibodies |
| 05/24/2012 | US20120128663 Fc VARIANTS THAT EXTEND ANTIBODY HALF-LIFE |
| 05/24/2012 | US20120128656 Vaccine compositions and methods |
| 05/24/2012 | US20120128655 Induced pluripotent stem cells |
| 05/24/2012 | US20120128647 Delivery of compounds with rehydrated blood cells |
| 05/24/2012 | US20120128643 Gene vector |
| 05/24/2012 | US20120128642 Potency markers |
| 05/24/2012 | US20120128641 Methods and compositions for improving the viability of cryopreserved cells |
| 05/24/2012 | US20120128640 Heterocyclic compounds and expansion agents for hematopoietic stem cells |
| 05/24/2012 | US20120128639 In Vitro Production Of Oligodendrocytes From Human Umbilical Cord Stem Cells |
| 05/24/2012 | US20120128638 Pharmaceutical composition for the treatment of heart diseases |
| 05/24/2012 | US20120128637 Cellular Seeding and Co-Culture of a Three Dimensional Fibroblast Construct |
| 05/24/2012 | US20120128636 Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction |
| 05/24/2012 | US20120128635 Methods and compositions for treating hemophilia b |
| 05/24/2012 | US20120128632 Identity markers |
| 05/24/2012 | US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence |
| 05/24/2012 | US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof |
| 05/24/2012 | US20120128624 Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects |
| 05/24/2012 | US20120128591 Anti-fap antibodies and methods of use |
| 05/24/2012 | US20120128586 Method for treating chronic lymphocytic leukemia |
| 05/24/2012 | US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level |
| 05/24/2012 | US20120125355 Transgenic Plants Comprising Constructs Encoding Phosphoenolpyruvate Carboxykinase and/or Pyruvate Orthophosphate Dikinase |
| 05/24/2012 | DE19780092B3 Verwendung eines Extrakts von Eriobotrya japonica insbesondere auf dem Gebiet der Kosmetik zur Stimulierung der Synthese der Glycosaminoglycane Use of an extract of Eriobotrya japonica and in particular the cosmetic field for stimulating the synthesis of glycosaminoglycans |
| 05/24/2012 | CA2818234A1 Generation of neural stem cells from human trophoblast stem cells |
| 05/24/2012 | CA2817964A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| 05/23/2012 | EP2455466A1 Dna fragment and pharmaceutical composition |
| 05/23/2012 | EP2455465A2 Amylase Variants |
| 05/23/2012 | EP2455454A1 Method for introducing a polynucleotide into plant protoplast cells |
| 05/23/2012 | EP2455453A1 Substrate for immobilizing cells or tissue |
| 05/23/2012 | EP2455452A1 Pluripotent stem cell that can be isolated from body tissue |
| 05/23/2012 | EP2455404A2 Anti-C5AR antibodies with improved properties |
| 05/23/2012 | EP2455399A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| 05/23/2012 | EP2455398A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| 05/23/2012 | EP2455111A2 Cell mass capable of serving as a primitive organ-like structure comprised of a plurality of cell types of somatic origin |
| 05/23/2012 | EP2455087A2 Isolation and identification of heparan sulphate |
| 05/23/2012 | EP2454594A1 Use of animal cells for screening probiotic bacteria strains |
| 05/23/2012 | EP2454363A2 Method for using directing cells for specific stem/progenitor cell activation and differentiation |
| 05/23/2012 | EP2454362A2 Hematopoietic stromal progenitor cells and uses thereof |
| 05/23/2012 | EP2454361A1 Cells, compositions and methods |
| 05/23/2012 | EP2454360A1 Methods for establishing symbioses |
| 05/23/2012 | EP2453905A2 Methods and compositions for in vitro and in vivo chondrogenesis |
| 05/23/2012 | EP2170369B1 Viral latency model |
| 05/23/2012 | EP2105498B1 Therapeutic composition for atopic dermatitis |
| 05/23/2012 | EP1799236B1 Liver stromal cells for prevention and treatment of immune responses in transplantation |